Tag: BioNTech

BioNTech to acquire Novartis’ Marburg manufacturing plant to expand production of COVID-19 vaccine candidates

pharmanewsdaily- September 18, 2020

Biopharmaceutical New Technologies (BioNTech) has agreed to acquire a GMP certified manufacturing facility in Marburg, Germany from Novartis to expand the production capacity of its ... Read More

Pfizer, BioNTech sign deal to supply BNT162 Covid-19 vaccine to Canada

pharmanewsdaily- August 6, 2020

Pfizer and BioNTech have signed an agreement with the Canadian government to supply their mRNA-based BNT162 vaccine candidate against SARS-CoV2, depending on clinical success and ... Read More

BNT162 COVID-19 vaccine candidate : US govt signs $2bn supply deal with Pfizer and BioNTech

pharmanewsdaily- July 22, 2020

Pfizer and BioNTech have bagged a $1.95 billion deal with the US government for supplying 100 million doses of their jointly developed BNT162 COVID-19 vaccine ... Read More

BNT162b1 and BNT162b2 Covid-19 vaccine candidates get FDA fast track status

pharmanewsdaily- July 14, 2020

Pfizer and BioNTech said that BNT162b1 and BNT162b2, two vaccine candidates developed to give protection against the SARS-CoV-2 virus have been given the fast track ... Read More

BioNTech, Pfizer join forces to develop mRNA-based flu vaccines

pharmanewsdaily- August 19, 2018

BioNTech, a German biotechnology company, has joined forces with US pharma giant Pfizer to develop mRNA-based flu vaccines as part of a $425 million multi-year ... Read More